ARIA guideline 2019 : treatment of allergic rhinitis in the German health system
Permalink
Citation
Klimek , L , Bachert , C , Pfaar , O , Becker , S , Bieber , T , Brehler , R , Buhl , R , Casper , I , Chaker , A , Czech , W , Fischer , J , Fuchs , T , Gerstlauer , M , Hoermann , K , Jakob , T , Jung , K , Kopp , M V , Mahler , V , Merk , H , Muelleneisen , N , Nemat , K , Rabe , U , Ring , J , Saloga , J , Schlenter , W , Schmidt-Weber , C , Seyfarth , H , Sperl , A , Spindler , T , Staubach , P , Strieth , S , Treudler , R , Vogelberg , C , Wallrafen , A , Wehrmann , W , Wrede , H , Zuberbier , T , Bedbrook , A , Canonica , G W , Cardona , V , Casale , T B , Czarlewski , W , Fokkens , W J , Hamelmann , E , Hellings , P W , Jutel , M , Larenas-Linnemann , D , Mullol , J , Papadopoulos , N G , Toppila-Salmi , S , Werfel , T & Bousquet , J 2019 , ' ARIA guideline 2019 : treatment of allergic rhinitis in the German health system ' , Allergo journal international , vol. 28 , no. 7 , pp. 255-276 . https://doi.org/10.1007/s40629-019-00110-9
| Title: | ARIA guideline 2019 : treatment of allergic rhinitis in the German health system |
| Author: | Klimek, Ludger; Bachert, Claus; Pfaar, Oliver; Becker, Sven; Bieber, Thomas; Brehler, Randolf; Buhl, Roland; Casper, Ingrid; Chaker, Adam; Czech, Wolfgang; Fischer, Joerg; Fuchs, Thomas; Gerstlauer, Michael; Hoermann, Karl; Jakob, Thilo; Jung, Kirsten; Kopp, Matthias V.; Mahler, Vera; Merk, Hans; Muelleneisen, Norbert; Nemat, Katja; Rabe, Uta; Ring, Johannes; Saloga, Joachim; Schlenter, Wolfgang; Schmidt-Weber, Carsten; Seyfarth, Holger; Sperl, Annette; Spindler, Thomas; Staubach, Petra; Strieth, Sebastian; Treudler, Regina; Vogelberg, Christian; Wallrafen, Andrea; Wehrmann, Wolfgang; Wrede, Holger; Zuberbier, Torsten; Bedbrook, Anna; Canonica, Giorgio W.; Cardona, Victoria; Casale, Thomas B.; Czarlewski, Wienczylawa; Fokkens, Wytske J.; Hamelmann, Eckard; Hellings, Peter W.; Jutel, Marek; Larenas-Linnemann, Desiree; Mullol, Joaquim; Papadopoulos, Nikolaos G.; Toppila-Salmi, Sanna; Werfel, Thomas; Bousquet, Jean |
| Contributor: | University of Helsinki, HUS Inflammation Center |
| Date: | 2019-11 |
| Language: | eng |
| Number of pages: | 22 |
| Belongs to series: | Allergo journal international |
| ISSN: | 2197-0378 |
| URI: | http://hdl.handle.net/10138/326736 |
| Subject: |
Allergen-specific immunotherapy
Allergic asthma Allergic diseases Health care system Integrated care pathway adrenergic receptor stimulating agent antihistaminic agent azelastine corticosteroid allergic disease allergic rhinitis anamnesis Article asthma atopic dermatitis comorbidity contact sensitization cross allergy desensitization drug cost drug utilization review health care system human neurodermatitis patient preference pollen allergy practice guideline randomized controlled trial (topic) respiratory tract disease visual analog scale 3121 General medicine, internal medicine and other clinical medicine |
| Rights: |
Files in this item
Total number of downloads: Loading...
| Files | Size | Format | View |
|---|---|---|---|
| Klimek2019_Arti ... eline2019TreatmentOfAl.pdf | 3.514Mb |
View/ |
This item appears in the following Collection(s)
-
Articles from TUHAT CRIS [40115]
Related items
Showing items related by title, author, creator and subject.
-
(2016)The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, prominent symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment adjustment is required. Clinical decision support systems (CDSSs) might be beneficial for the assessment of disease control. CDSSs should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine treatment and its step-up or step-down strategy depending on AR control. Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR [fighting chronic diseases for active and healthy ageing]), one of the reference sites of the European Innovation Partnership on Active and Healthy Ageing, has initiated an allergy sentinel network (the MACVIA-ARIA Sentinel Network). A CDSS is currently being developed to optimize AR control. An algorithm developed by consensus is presented in this article. This algorithm should be confirmed by appropriate trials.
-
(2021)Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.
-
(2019)Pharmacists are trusted health care professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in integrated care pathways (ICPs) for allergic diseases is important. This paper builds on existing studies and provides tools intended to help pharmacists provide optimal advice/interventions/strategies to patients with rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA)-pharmacy ICP includes a diagnostic questionnaire specifically focusing attention on key symptoms and markers of the disease, a systematic Diagnosis Guide (including differential diagnoses), and a simple flowchart with proposed treatment for rhinitis and asthma multimorbidity. Key prompts for referral within the ICP are included. The use of technology is critical to enhance the management of allergic rhinitis. However, the ARIA-pharmacy ICP should be adapted to local healthcare environments/situations as regional (national) differences exist in pharmacy care.